Steroid-toxicity insights

During 2023, the Steritas team had the opportunity to speak with a range of inspiring clinical research leaders who shared their expertise with us and our colleagues. Every conversation underscored ...

Although ongoing research continues to advance our understanding of IgG4-related disease (IgG4-RD), the epidemiology and downstream consequences of this relatively rare and complex autoimmune ...

“Anywhere that steroids are being used in clinical studies, especially randomized controlled studies, there is a place for the GTI.” Paul Brunetta, MD is a physician and clinical researcher with 14 ...

Ever since the introduction of the Steritas Glucocorticoid Toxicity Index (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...

Results from a Phase 3 clinical trial reported in The New England Journal of Medicine,[1] have highlighted the significant unmet need for effective long-term treatments for those battling polymyalgia ...